RxDoctor Payments Data

Eleanor Jenkins-Alford, MD

Family Medicine · Goose Creek, SCNPI 1689743569

Payments from drug & device makers

$406in general payments, 2019–2025

Across 17 payments — averaging $23.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$130
  • Lilly USA, LLC$61
  • Exact Sciences$44
  • Sunovion Pharmaceuticals Inc.$43
  • Johnson & Johnson$39
  • Merck$34
  • plus $56 from 3 others

What the payments were for

  • Food & beverage$406100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$406 in reported general payments places this provider in the 45th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$514
Medicare patients
45
Services billed
59

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide81$77,686
JardianceEmpagliflozin65$74,012
TrulicityDulaglutide60$72,708
JanuviaSitagliptin Phosphate59$43,259
EliquisApixaban30$33,104
JanumetSitagliptin Phos/Metformin Hcl27$18,065
XareltoRivaroxaban25$16,486
MounjaroTirzepatide15$15,668
LinzessLinaclotide16$10,501
FarxigaDapagliflozin Propanediol12$8,088
SymbicortBudesonide/Formoterol Fumarate20$7,293
Lantus SolostarInsulin Glargine,hum.Rec.Anlog44$5,856
Albuterol Sulfate HfaAlbuterol Sulfate123$3,917
Atorvastatin Calcium353$3,671
Rosuvastatin Calcium119$2,807

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$61$88,37675 claims
Novo NordiskOzempic$19$77,68681 claims
MerckJanuvia, Janumet$34$61,32486 claims
Johnson & JohnsonXarelto$39$16,48625 claims
AstraZenecaFarxiga, Symbicort$130$15,38132 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Goose Creek

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →